IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
Total Current Assets Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
Total Current Assets
kr123.6m
CAGR 3-Years
-24%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
Total Current Assets
kr1.2B
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
Total Current Assets
kr3.2B
CAGR 3-Years
69%
CAGR 5-Years
56%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
Total Current Assets
kr1.1B
CAGR 3-Years
-10%
CAGR 5-Years
73%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
Total Current Assets
kr69.5m
CAGR 3-Years
-25%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
Total Current Assets
kr987.4m
CAGR 3-Years
26%
CAGR 5-Years
80%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's Total Current Assets?
Total Current Assets
123.6m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's Total Current Assets amounts to 123.6m SEK.

What is IRLAB Therapeutics AB's Total Current Assets growth rate?
Total Current Assets CAGR 5Y
-3%

Over the last year, the Total Current Assets growth was -54%. The average annual Total Current Assets growth rates for IRLAB Therapeutics AB have been -24% over the past three years , -3% over the past five years .

Back to Top